A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer.

Sanjay Kumar YadavS BharathDhananjaya Sharma Anurag SrivastavaChandan Kumar JhaGaurav AgarwalSarada KhadkaManju SinghSaket ShekharAmit Goyal

Published in: Breast cancer research and treatment (2024)

Fluorescein-guided SLNB is a viable option for detection of lymph node metastases in clinically node negative patients with early breast cancer. It achieves a high pooled Sentinel Lymph Node Identification Rate (SLN-IR) of 93% with a false negative rate of 5.6% for the detection of axillary lymph node metastasis.

Keyphrases

sentinel lymph node
lymph node
early breast cancer
lymph node metastasis
neoadjuvant chemotherapy
early stage
loop mediated isothermal amplification
squamous cell carcinoma
real time pcr
label free
randomized controlled trial
clinical trial
radiation therapy
quantum dots